Avid Bioservices Q4 Sales $39.41M Beat $38.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Avid Bioservices reported Q4 sales of $39.41 million, beating the analyst consensus estimate of $38.90 million by 1.31% and marking a 26.20% increase over the same period last year.
June 21, 2023 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avid Bioservices' Q4 sales surpassed estimates by 1.31% at $39.41 million, a 26.20% YoY increase.
Avid Bioservices' Q4 sales exceeded analyst expectations by 1.31%, which is a positive signal for investors. The 26.20% YoY increase in sales indicates strong growth, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100